OrthoPediatrics Corporation has expanded its partnership with iotaMotion to bring the iotaSOFT® robotic-assisted cochlear implant insertion system to pediatric patients. Following FDA 510(k) clearance, the iotaSOFT system is now authorized for use in children four years of age and older, extending advanced cochlear implantation technology to school-aged children. This collaboration supports OrthoPediatrics’ strategy to broaden its impact beyond orthopedics and into pediatric ENT care, utilizing cutting-edge technology to improve clinical outcomes. Cincinnati Children's Hospital has become the first dedicated pediatric center to adopt the iotaSOFT system, joining over 35 leading cochlear implant centers across the United States.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OrthoPediatrics Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9647311-en) on February 03, 2026, and is solely responsible for the information contained therein.